HighTide Therapeutics, Inc. 君聖泰醫藥

Pay for financial year ended 2024-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Hung, Tak Wai (SFC:BQQ641) 孔德偉 INED 184 184
2 Jiang, Feng (1979) 江峰 NED
3 Li, Jin (1965) 李靖 INED 184 184
4 Li, Li (Shenzhen Hepalink) 李鋰 NED
5 Liu, Liping (1969) 劉利平 Ch, CEO, Fdr 2,913 38 8,479 11,430
6 Ma, Lixiong (1974) 馬立雄 NED 12,227 12,227
7 Tan, Bo (1973) 譚擘 INED 184 184
8 Yu, Meng (1981) 于萌 ED 1,105 118 10,604 11,827
9 Zhu, Xun (1958) 朱迅 NED 506 787 1,293
Total 552 4,524 0 156 32,097 37,329

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 552 4,524 0 156 32,097 37,329 Report
2023-12-31 12 5,272 0 149 30,988 36,421 Report
Total 564 9,796 0 305 63,085 73,750

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top